BOOK
Modern Management of Benign and Malignant Pancreatic Disease, An Issue of Gastroenterology Clinics - E-Book
(2012)
Additional Information
Book Details
Abstract
Dr. Van Dam is an internationally recognized leader in gastroenterology and has been a leader in advances in intervedntional endoscopy. He brings this expertise to the topic of management of benign and malignant pancreatic disease and has selected top experts in the field to provide state-of-the-art clinical information to gastroenterologists. The modern management treatise of each article addresses current diagnostics as well as medical management. Seven articles are devoted to pancreatic cancer and span medical management, surgial mangament, radiologic imaging, endoscopic diagnosis, palliation, and screening. Other important topics addressed are pancreatic transplantation, pancreatic cystic neoplasms, acute and chronic pancreatitis, and autoimmune pancreatitis.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover | Cover | ||
Gastroenterology Clinics of North America | i | ||
Copyright Page | ii | ||
Table of Contents | vii | ||
Contributors | iii | ||
Preface: Modern Management of Pancreatic Disease | xiii | ||
Chapter 1. Modern Management of Acute Pancreatitis | 1 | ||
BURDEN OF ACUTE PANCREATITIS IN THE MODERN ERA | 1 | ||
INITIAL ASSESSMENT OF SEVERITY | 1 | ||
EARLY FLUID RESUSCITATION | 2 | ||
APPROPRIATE USE OF RADIOGRAPHIC IMAGING IN THE EARLY PHASE OF ACUTE PANCREATITIS | 3 | ||
NUTRITIONAL SUPPORT | 4 | ||
MANAGEMENT OF LOCAL COMPLICATIONS | 4 | ||
MANAGEMENT OF SYSTEMIC COMPLICATIONS | 5 | ||
SECONDARY PREVENTION | 5 | ||
ADDITIONAL ETIOLOGIES | 6 | ||
SUMMARY | 6 | ||
REFERENCES | 6 | ||
Chapter 2. Diagnosis and Management of Autoimmune Pancreatitis | 9 | ||
SUBTYPES OF AIP | 9 | ||
PATHOPHYSIOLOGY | 10 | ||
HISTOLOGY | 11 | ||
CLINICAL CONTEXT | 11 | ||
IMAGING | 12 | ||
SEROLOGY | 14 | ||
OTHER ORGAN INVOLVEMENT | 15 | ||
DIAGNOSIS | 16 | ||
TREATMENT | 17 | ||
SUMMARY | 18 | ||
REFERENCES | 18 | ||
Chapter 3. The Role of Endoscopic Retrograde Cholangiopancreatography in Patients with Pancreatic Disease | 23 | ||
GALLSTONE PANCREATITIS | 23 | ||
IDIOPATHIC PANCREATITIS | 25 | ||
CHRONIC PANCREATITIS | 30 | ||
PANCREATIC DUCT LEAKS | 34 | ||
POST-ERCP PANCREATITIS | 37 | ||
SUMMARY | 40 | ||
REFERENCES | 40 | ||
Chapter 4. Endoscopic Management of Pancreatic Pseudocysts | 47 | ||
DISTINGUISHING PSEUDOCYSTS FROM PANCREATIC CYSTIC NEOPLASMS | 47 | ||
INDICATIONS FOR DRAINAGE OF PANCREATIC PSEUDOCYSTS | 49 | ||
DRAINAGE TECHNIQUES | 49 | ||
SURGICAL DRAINAGE | 57 | ||
SUMMARY | 58 | ||
REFERENCES | 59 | ||
Chapter 5. Modern Treatment of Patients with Chronic Pancreatitis | 63 | ||
PAIN MANAGEMENT | 63 | ||
PANCREATIC EXOCRINE INSUFFICIENCY | 70 | ||
PANCREATIC ENDOCRINE INSUFFICIENCY | 71 | ||
SUMMARY | 71 | ||
REFERENCES | 71 | ||
Chapter 6. The Minimally Invasive Approach to Surgical Management of Pancreatic Diseases | 77 | ||
SURGICAL TECHNIQUES FOR LAPAROSCOPIC SURGERY ON THE PANCREAS | 77 | ||
MINIMALLY INVASIVE APPROACH TO THE TREATMENT OF PANCREATIC NECROSIS | 78 | ||
THE ROLE OF LAPAROSCOPY IN THE TREATMENT OF CHRONIC PANCREATITIS | 86 | ||
THE LAPAROSCOPIC APPROACH TO THE TREATMENT OF PANCREATIC TUMORS | 88 | ||
SUMMARY | 97 | ||
REFERENCES | 98 | ||
Chapter 7. Pancreatic Cystic Neoplasms: Diagnosis and Management | 103 | ||
THE MAJOR PANCREATIC CYSTIC NEOPLASMS | 103 | ||
RECENT DEVELOPMENTS | 110 | ||
APPROACH TO INCIDENTAL PANCREATIC CYSTIC LESIONS | 112 | ||
SUMMARY | 113 | ||
REFERENCES | 113 | ||
Chapter 8. Management of Pancreatic Neuroendocrine Tumors | 119 | ||
CAUSES AND GENETICS | 119 | ||
CLINICAL PRESENTATION AND DIAGNOSIS | 120 | ||
IMAGING MODALITIES | 122 | ||
STAGING, GRADE, AND PROGNOSIS | 123 | ||
MANAGEMENT OF LOCALIZED DISEASE | 124 | ||
MANAGEMENT OF ADVANCED DISEASE | 124 | ||
FUTURE DIRECTIONS | 127 | ||
REFERENCES | 128 | ||
Chapter 9. Pancreas Transplantation | 133 | ||
PANCREAS ORGAN DONORS | 133 | ||
SURGICAL PROCEDURE | 134 | ||
SURGICAL COMPLICATIONS AFTER PANCREAS TRANSPLANTATION | 135 | ||
IMPACT OF PANCREAS TRANSPLANTATION ON PATIENT SURVIVAL | 136 | ||
IMPACT OF PANCREAS TRANSPLANTATION ON DIABETES-RELATED COMPLICATIONS | 137 | ||
SUMMARY | 139 | ||
REFERENCES | 139 | ||
Chapter 10. Pancreatic Cancer Screening | 143 | ||
PANCREATIC CANCER: WHY CONSIDER SCREENING? | 143 | ||
GENETIC PREDISPOSITION TO PANCREATIC CANCER | 143 | ||
INHERITED CANCER SYNDROMES | 144 | ||
TARGETS FOR SCREENING AND SURVEILLANCE | 145 | ||
AVAILABLE AND ANTICIPATED TUMOR MARKERS | 146 | ||
APPROACHES TO SCREENING | 147 | ||
SUMMARY | 150 | ||
REFERENCES | 150 | ||
Chapter 11. Pancreatic Cancer: Radiologic Imaging | 159 | ||
CLINICAL OVERVIEW | 159 | ||
MDCT AND MRI TECHNIQUE | 160 | ||
MDCT AND MRI FINDINGS IN PANCREATIC ADENOCARCINOMA | 165 | ||
MDCT AND MRI STAGING OF PANCREATIC ADENOCARCINOMA | 168 | ||
OVERALL ACCURACY OF MDCT STAGING FOR PANCREATIC CARCINOMA | 172 | ||
PITFALLS IN THE DIAGNOSIS OF PANCREATIC ADENOCARCINOMA | 172 | ||
NEW HORIZONS IN MDCT ASSESSMENT OF PANCREATIC ADENOCARCINOMA | 174 | ||
REFERENCES | 174 | ||
Chapter 12. The Role of Endoscopic Ultrasonography in the Diagnosis and Management of Pancreatic Cancer | 179 | ||
THE ROLE OF EUS IN DIAGNOSIS OF PANCREATIC CANCER | 179 | ||
LIMITATIONS OF EUS | 180 | ||
NEWER EUS TECHNOLOGIES FOR THE DETECTION OF PANCREATIC CANCER | 181 | ||
THERAPEUTIC USES OF EUS IN PANCREATIC CANCER | 183 | ||
SUMMARY | 185 | ||
REFERENCES | 185 | ||
Chapter 13. Pancreatic Cancer: Medical Management (Novel Chemotherapeutics) | 189 | ||
TREATMENT OF RESECTABLE DISEASE | 190 | ||
TREATMENT OF LOCALLY ADVANCED DISEASE | 193 | ||
TREATMENT OF METASTATIC AND RECURRENT DISEASE | 195 | ||
SUMMARY | 202 | ||
REFERENCES | 202 | ||
Chapter 14. The Surgical Management of Pancreatic Cancer | 211 | ||
PANCREATICODUODENECTOMY | 211 | ||
PANCREATICODUODENECTOMY VERSUS PYLORUS-PRESERVING PANCREATICODUODENECTOMY | 213 | ||
DISTAL PANCREATECTOMY | 214 | ||
EXTENDED RESECTION | 214 | ||
SUMMARY | 218 | ||
REFERENCES | 218 | ||
Chapter 15. Modern Radiation Therapy Techniques for Pancreatic Cancer | 223 | ||
RADIOTHERAPY IN THE TREATMENT OF PANCREATIC ADENOCARCINOMA | 224 | ||
TARGET DEFINITION AND IMAGE-GUIDED RADIATION THERAPY | 224 | ||
IMAGE GUIDANCE DURING TREATMENT DELIVERY | 226 | ||
INTENSITY-MODULATED RADIOTHERAPY | 227 | ||
ARC THERAPY | 228 | ||
STEREOTACTIC ABLATIVE BODY RADIOTHERAPY | 229 | ||
TECHNICAL CONSIDERATIONS | 230 | ||
CLINICAL EVIDENCE | 230 | ||
SUMMARY | 232 | ||
REFERENCES | 232 | ||
Chapter 16. Endoscopic Palliation of Pancreatic Cancer | 237 | ||
THE BASIC PRINCIPLE OF PALLIATION | 238 | ||
BILIARY OBSTRUCTION | 239 | ||
GASTRODUODENAL OBSTRUCTION | 242 | ||
POSTOPERATIVE INTESTINAL OBSTRUCTION | 243 | ||
DISABLING ABDOMINAL AND BACK PAIN | 243 | ||
GASTROINTESTINAL HEMORRHAGE | 245 | ||
POSTOPERATIVE PANCREATIC FISTULA | 246 | ||
LOCAL CANCER GROWTH | 246 | ||
COMPLICATIONS OF ENDOSCOPIC THERAPY | 246 | ||
SUMMARY | 248 | ||
REFERENCES | 248 | ||
Index | 255 |